BridgeMD
New treatment option for Subacromial Impingement Syndrome
Official title Effects of Kinesio Taping on Thoracolumbar Fascia Flexibility in Patients With Shoulder Injury
ClinicalTrials.gov ID: NCT07624136
What this study is testing
- What it's testing
- The aim of this randomized controlled trial is to investigate the acute effects of fascia correction Kinesio Taping applied to the thoracolumbar fascia (TLF) in individuals with Subacromial Impingement Syndrome (SIS). Participants will be randomly allocated into an intervention group and a sham taping control group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 40. Healthy volunteers may be eligible.
You may be able to join if
- age between 20 and 40 years,
- Body Mass Index (BMI) within the normal range (20-24.9 kg/m²),
- a chronic (symptoms persisting for \>3 months) SIS diagnosis
You likely can't join if
- any shoulder pathology other than SIS (e.g., rotator cuff tear, glenohumeral joint problems),
- inability to perform 90° shoulder flexion due to joint limitation or pain ≥8 on the VAS,
- overweight or obesity (BMI \>25 kg/m²),
- previous back surgery,
- low back pain within the last six months, scoliosis, radiologically diagnosed kyphosis or thoracolumbar disc herniation, sacroiliac joint problems...
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Altindag, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Altindag, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.